Skip to content

Effect evaluation of different protein intake regimens in critical illness patients

Effect evaluation of different protein intake regimens in critical illness patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300075386
Enrollment
Unknown
Registered
2023-09-04
Start date
2023-03-28
Completion date
Unknown
Last updated
2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical illness

Interventions

Adequate protein group:N/A
Low protein group:N/A

Sponsors

Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) All subjects are adults over 18 years old; (2) Subjects used nutritional preparations during ICU stay; (3) Subjects are expected to stay in ICU for more than 9 days; (4) All subjects or their family members are willing to participate in the test and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) The subjects have abnormal secretion of other hormones, such as thyroid hormone, parathyroid hormone, adrenotropic hormone, growth hormone, etc.; (2) patients with severe burn; (3) The subject is pregnant or lactating. (4) Patients with severe liver insufficiency, severe renal insufficiency and no hemofiltration; (5) patients with advanced malignant tumor and fluid deficiency; (6) Patients in shock, hemodynamic instability and still requiring high dose of norepinephrine 3 days after entry;

Design outcomes

Primary

MeasureTime frame
28-day mortality rate;Length of ICU stay;

Secondary

MeasureTime frame
Laboratory indicators serum total protein (TP), serum albumin (ALB), prealbumin (PA), C-reactive protein (CRP);Serum amino acid content reached the standard rate;Total length of stay;

Countries

China

Contacts

Public ContactXiaojie Bian

Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School

18061678828@189.cn+86 180 6167 8828

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026